News & Updates

SGLT2is do not increase fracture risk in type 2 diabetes
SGLT2is do not increase fracture risk in type 2 diabetes
02 Apr 2022

Type 2 diabetes patients who use sodium-glucose cotransporter 2 inhibitors (SGLT2is) see no increase in the risk of fractures, a recent Korea study has found.

SGLT2is do not increase fracture risk in type 2 diabetes
02 Apr 2022